Pharmacist Intervention for Smoking Cessation
What You Need to Know Before You Apply
What is the purpose of this trial?
The goal of this study is to assess the effectiveness of a remote pharmacist intervention to help smokers quit.
The main questions it aims to answer are:
* Will smokers being screened for lung cancer with low-radiation-level chest computed tomography (CT) be willing to participate in this study and talk to the pharmacist about smoking cessation?
* Will those in the intervention group be more likely to report smoking cessation than those in the control group.
Participants in the intervention group will be asked to complete a baseline survey; speak with a pharmacist via phone call at baseline, 2 weeks, 4 weeks, 6 weeks, 8 weeks, 10 weeks, and 12 weeks; and complete an exit survey.
Participants in the control group will be asked to complete a baseline survey and an exit survey.
Who Is on the Research Team?
Jacob E Simmering, PhD
Principal Investigator
University of Iowa
Are You a Good Fit for This Trial?
This trial is for current smokers enrolled in the Lung Cancer Screening Program. It's designed to see if talking with a pharmacist over the phone can help them quit smoking, especially those getting low-radiation chest CT scans.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants in the intervention group complete a baseline survey and have phone calls with a pharmacist at baseline, 2, 4, 6, 8, 10, and 12 weeks
Control
Participants in the control group complete a baseline survey and an exit survey
Follow-up
Participants are monitored for smoking cessation success and use of nicotine replacement therapies
What Are the Treatments Tested in This Trial?
Interventions
- Pharmacist Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Iowa
Lead Sponsor